CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Events Archives

Webinar: Consultation on Proposal to Integrate Key Functions of the Cancer Drug Implementation Advisory Committee into CADTH’s pan-Canadian Oncology Drug Review Process

March 4, 2019
CADTH, in collaboration with CAPCA, invites stakeholder input on the proposed changes to the pCODR process. As part of this consultation, CADTH and CAPCA will be holding a webinar on Monday, March 4, 2019, from 12:00 p.m. to 1:00 p.m. EST. Panelists Heather Logan (Senior Advisor, CADTH), Alexandra Chambers (Director, pCODR), and Erika Brown (...

CADTH Drug Portfolio Information Session

November 1, 2018
This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from CADTH’s pharmaceutical reviews portfolio, including the CADTH Common Drug Review (CDR), the CADTH pan-Canadian Oncology Drug Review (pCODR), and Therapeutic Reviews. Updates on other relevant CAD...

CADTH Medical Devices Portfolio Information Session

November 1, 2018
Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This session will cover the role of HTA in the management of medical devices in Canada, the programs in CADTH’s medical devices and clinical interventions portfolio, the assessment processes CADTH follows, and the opportunities for input ...

Defining "Decision-Grade Real World Evidence” and its Role in the Canadian Context: A Design Sprint — Pre-Conference Workshop / CAPT Annual Conference

October 21, 2018
CADTH, in partnership with Health Canada, the Institute of Health Economics (IHE), and the Canadian Association for Population Therapeutics (CAPT) is hosting a special workshop to solicit input from stakeholders into the development of frameworks for the use of real world evidence in regulatory and reimbursement decision-making. The daylong int...